June 2021, Aiforia, Finland

June 2021, Aiforia, Finland, (https://www.aiforia.com), announced that it raised 12.6M euro in series B funding to enhance precision diagnostics and preclinical analysis in pathology. Aiforia is a leading provider of AI-based deep learning software solutions for clinical and preclinical image analysis in pathology across a variety of fields, from oncology to neuroscience. The company’s cloud-based software has more than 3,000 users in 50+ countries. Aiforia had previously announced that it had secured a US patent for their high-speed AI training tool in medical image analysis. Aiforia is headquartered in Helsinki, Finland and has its North American office in Cambridge, Massachusetts.